Home LiteratureArticle Details
PMID: 8608630 Published · ppublish English Editorial Review

Antigen-specific immunotherapy of autoimmune disease: a commentary.

Clinical and experimental immunology ·Vol. 103 ·No. 3 ·1996-03-00 ·Pages 349-52

Wraith DC

Abstract

暂无摘要

MeSH Terms
Animals Antigens/therapeutic use Autoimmune Diseases/immunology,therapy Humans Immunotherapy T-Lymphocytes/immunology
Chemicals
Antigens
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Wraith D C
Department of Pathology, University of Bristol School of Medical Sciences, UK.
References (36)
36 references, click to expand
  1. Inhibition of specific immune responses by feeding protein antigens.
    Int Arch Allergy Appl Immunol. 1977;55(1-6):526-32 PMID: 591113
  2. Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity.
    Int Immunol. 1993 Sep;5(9):1159-65 PMID: 7694644
  3. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo.
    Immunity. 1994 Jul;1(4):327-39 PMID: 7889419
  4. Suppression of an established DTH response to ovalbumin in mice by feeding antigen after immunization.
    Immunology. 1988 May;64(1):135-9 PMID: 3384449
  5. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens.
    Annu Rev Immunol. 1994;12:809-37 PMID: 8011298
  6. Intranasal administration of retinal antigens suppresses retinal antigen-induced experimental autoimmune uveoretinitis.
    Immunology. 1994 Aug;82(4):625-31 PMID: 7835927
  7. Immunotherapy of autoimmune disease.
    Curr Opin Immunol. 1993 Dec;5(6):925-33 PMID: 8297526
  8. Low avidity recognition of self-antigen by T cells permits escape from central tolerance.
    Immunity. 1995 Oct;3(4):407-15 PMID: 7584132
  9. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis.
    Science. 1994 Aug 26;265(5176):1237-40 PMID: 7520605
  10. Antigen presentation by macrophage-enriched cells from the mouse Peyer's patch.
    Cell Immunol. 1981 Jul 15;62(1):110-8 PMID: 6973404
  11. Priming of systemic and local delayed-type hypersensitivity responses by feeding low doses of ovalbumin to mice.
    Immunology. 1989 Apr;66(4):595-9 PMID: 2714839
  12. The natural immune response to inhaled soluble protein antigens involves major histocompatibility complex (MHC) class I-restricted CD8+ T cell-mediated but MHC class II-restricted CD4+ T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production.
    J Exp Med. 1993 Sep 1;178(3):889-99 PMID: 8102390
  13. Depletion of suppressor T cells by 2'-deoxyguanosine abrogates tolerance in mice fed ovalbumin and permits the induction of intestinal delayed-type hypersensitivity.
    Immunology. 1986 Jun;58(2):179-84 PMID: 2940171
  14. Targeting autoantigen to B cells prevents the induction of a cell-mediated autoimmune disease in rats.
    J Exp Med. 1992 Mar 1;175(3):655-9 PMID: 1740660
  15. Oral tolerance in experimental autoimmune uveoretinitis. Distinct mechanisms of resistance are induced by low dose vs high dose feeding protocols.
    J Immunol. 1993 Nov 15;151(10):5751-61 PMID: 7693817
  16. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy.
    Cell. 1992 Dec 24;71(7):1065-8 PMID: 1335362
  17. Specific inhibition of antibody production. I. Protein-over loading paralysis.
    Immunology. 1962 Jan;5:161-8 PMID: 13887797
  18. Mucosal tolerance and suppression of collagen-induced arthritis (CIA) induced by nasal inhalation of synthetic peptide 184-198 of bovine type II collagen (CII) expressing a dominant T cell epitope.
    Clin Exp Immunol. 1996 Mar;103(3):368-75 PMID: 8608633
  19. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen.
    Nature. 1992 Jul 9;358(6382):155-7 PMID: 1377368
  20. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy.
    Cell. 1995 Mar 10;80(5):707-18 PMID: 7534215
  21. Determinant spreading and the dynamics of the autoimmune T-cell repertoire.
    Immunol Today. 1993 May;14(5):203-8 PMID: 7686009
  22. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering.
    Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):421-5 PMID: 1370356
  23. Inhibition of specific immune responses by feeding protein antigens. IV. Evidence for tolerance and specific active suppression of cell-mediated immune responses to ovalbumin.
    J Immunol. 1979 Nov;123(5):2344-50 PMID: 90707
  24. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis.
    Science. 1994 Feb 25;263(5150):1139-43 PMID: 7509084
  25. Affinity for class II MHC determines the extent to which soluble peptides tolerize autoreactive T cells in naive and primed adult mice--implications for autoimmunity.
    Int Immunol. 1995 Aug;7(8):1255-63 PMID: 7495732
  26. Reversal of experimental autoimmune encephalomyelitis by a soluble peptide variant of a myelin basic protein epitope: T cell receptor antagonism and reduction of interferon gamma and tumor necrosis factor alpha production.
    J Exp Med. 1994 Dec 1;180(6):2227-37 PMID: 7525850
  27. Orally induced tolerance. Definition at the cellular level.
    Int Arch Allergy Appl Immunol. 1981;65(3):323-38 PMID: 6165688
  28. Could specific oral tolerance be a therapy for autoimmune disease?
    Immunol Today. 1990 Nov;11(11):396-9 PMID: 2078293
  29. Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice.
    J Exp Med. 1993 Nov 1;178(5):1783-8 PMID: 8228823
  30. Mucosal tolerance in a murine model of experimental autoimmune encephalomyelitis.
    Ann N Y Acad Sci. 1996 Feb 13;778:228-42 PMID: 8610976
  31. Prevention of experimental allergic encephalomyelitis in rats by targeting autoantigen to B cells: evidence that the protective mechanism depends on changes in the cytokine response and migratory properties of the autoantigen-specific T cells.
    J Exp Med. 1995 Aug 1;182(2):335-44 PMID: 7543135
  32. The new era of immunosuppressive therapy in autoimmune diseases.
    Transplant Proc. 1991 Dec;23(6):3319-21 PMID: 1750093
  33. Antigen-driven bystander suppression after oral administration of antigens.
    J Exp Med. 1991 Oct 1;174(4):791-8 PMID: 1717632
  34. Immunological unresponsiveness.
    Adv Immunol. 1973;16:61-122 PMID: 4125922
  35. Partial characterization of a circulating tolerogenic moiety which, after a feed of ovalbumin, suppresses delayed-type hypersensitivity in recipient mice.
    Immunology. 1995 Nov;86(3):480-6 PMID: 8550089
  36. Antigen-driven peripheral immune tolerance. Suppression of organ-specific autoimmune diseases by oral administration of autoantigens.
    Ann N Y Acad Sci. 1991 Dec 30;636:227-32 PMID: 1793212
Article Info
Journal
Clinical and experimental immunology
Abbr.
Clin Exp Immunol
ISSN
0009-9104
DOI
10.1111/j.1365-2249.1996.tb08286.x
Published
1996-03-00
Pages
349-52
Language
English
Region
England
NLM ID
0057202
PMCID
PMC2200373
Subset
IM
External Links
PubMed source DOI: 10.1111/j.1365-2249.1996.tb08286.x PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2